13C-nuclear magnetic resonance spectroscopy studies of hepatic glucose metabolism in normal subjects and subjects with insulin-dependent diabetes mellitus.
about
Control of mammalian glycogen synthase by PAS kinaseOverexpression of 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase in mouse liver lowers blood glucose by suppressing hepatic glucose productionCloning and characterization of the human and rat islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP) genesActivation of direct and indirect pathways of glycogen synthesis by hepatic overexpression of protein targeting to glycogenHepatocyte nuclear factor-1 acts as an accessory factor to enhance the inhibitory action of insulin on mouse glucose-6-phosphatase gene transcriptionMagnetic resonance spectroscopy to study hepatic metabolism in diffuse liver diseases, diabetes and cancer.Loss of Par-1a/MARK3/C-TAK1 kinase leads to reduced adiposity, resistance to hepatic steatosis, and defective gluconeogenesis.High-sensitivity, broadband-decoupled (13) C MR spectroscopy in humans at 7T using two-dimensional heteronuclear single-quantum coherence.Glycogen synthase kinase-3 in insulin and Wnt signalling: a double-edged sword?Pulsatile portal vein insulin delivery enhances hepatic insulin action and signaling.Insulin Resistance in Human iPS Cells Reduces Mitochondrial Size and Function.Restoration of euglycemia after duodenal bypass surgery is reliant on central and peripheral inputs in Zucker fa/fa rats.Restoration of hepatic glucokinase expression corrects hepatic glucose flux and normalizes plasma glucose in zucker diabetic fatty rats.Activation of basal gluconeogenesis by coactivator p300 maintains hepatic glycogen storage.Mechanism of impaired insulin-stimulated muscle glucose metabolism in subjects with insulin-dependent diabetes mellitus.Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans.Hepatic steatosis in type 1 diabetes.Liver glycogen metabolism during and after prolonged endurance-type exercise.The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans.Protein kinase A phosphorylates hepatocyte nuclear factor-6 and stimulates glucose-6-phosphatase catalytic subunit gene transcription.Sequence variation between the mouse and human glucose-6-phosphatase catalytic subunit gene promoters results in differential activation by peroxisome proliferator activated receptor gamma coactivator-1alphaSTAT3 targets the regulatory regions of gluconeogenic genes in vivoSemecarpus anacardium (Bhallataka) Alters the Glucose Metabolism and Energy Production in Diabetic Rats.The three insulin response sequences in the glucose-6-phosphatase catalytic subunit gene promoter are functionally distinct.Prandial insulin and the systemic appearance of meal-derived glucose in people with type 1 diabetes.Overexpression of the P46 (T1) translocase component of the glucose-6-phosphatase complex in hepatocytes impairs glycogen accumulation via hydrolysis of glucose 1-phosphate.Selective tonic inhibition of G-6-Pase catalytic subunit, but not G-6-P transporter, gene expression by insulin in vivo.Glycogen-targeting subunits and glucokinase differentially affect pathways of glycogen metabolism and their regulation in hepatocytes.Reversal of diet-induced glucose intolerance by hepatic expression of a variant glycogen-targeting subunit of protein phosphatase-1.Effect of enteral vs. parenteral glucose delivery on initial splanchnic glucose uptake in nondiabetic humans.Identification of phenylbutyrylglutamine, a new metabolite of phenylbutyrate metabolism in humans.Hepatic expression of a targeting subunit of protein phosphatase-1 in streptozotocin-diabetic rats reverses hyperglycemia and hyperphagia despite depressed glucokinase expression.Sweet dreams?--nocturnal hypoglycemia in children with type 1 diabetes.Regulation of hepatic metabolism by enteral delivery of nutrients.Glucose production, recycling, and gluconeogenesis in normals and diabetics: a mass isotopomer [U-13C]glucose study.The consequences of long-term glycogen synthase kinase-3 inhibition on normal and insulin resistant rat hearts.Distinctive regulatory and metabolic properties of glycogen-targeting subunits of protein phosphatase-1 (PTG, GL, GM/RGl) expressed in hepatocytes.Human liver glycogen metabolism assessed with a 13C-enriched diet and a 13CO2 breath test.Fasting and postprandial liver glycogen content in patients with type 1 diabetes mellitus after successful pancreas-kidney transplantation with systemic venous insulin delivery.Elevated NEFA levels impair glucose effectiveness by increasing net hepatic glycogenolysis.
P2860
Q24294232-4F0EDC99-03F0-4470-B344-F49B9E2F06F7Q28345388-A8CAD2E1-7CE4-4DD3-BE12-EA2FA2CF528AQ28505669-672CAF76-3E58-4DEF-9FD9-144300C4C251Q28511989-8A2A7E38-92F8-4BA0-B1FE-F1447FEE1C6FQ28513198-130E18DD-67AA-4CB2-953F-39B00CE2AD36Q33764772-9AAA9C93-1740-483A-A0AD-8994A189827BQ34190237-34D6841F-6DD7-4A1F-A89E-C2611398BCE4Q35226543-7E263BB4-F8B0-48DE-A965-266FD8C455DAQ35922886-D56D9871-A576-4F9F-9086-B7D569251C93Q36182573-6E2C591E-EB60-4921-AA81-52E1E40C0D37Q36656956-024496DB-765E-4AF4-9504-40CBB2C7DC19Q36720617-0F9CC0C2-8B06-46C3-94AA-0D287E11A1FEQ37023109-B47A1383-980E-4109-82AB-6BF5812A86A8Q37050347-CD06070C-3CAA-4F87-AE4D-839922D6D701Q37366705-4014D7D7-685D-414F-8326-52BA18D82928Q37379144-71905C45-006B-4EE7-8522-C64DD14A111DQ38009669-8225AC1F-1985-4BC5-B099-6DD3AACD6DE0Q38902789-0D9F912F-A13C-449D-B1C9-0031C01E36D2Q39759818-F373B484-8067-4C85-BC74-D4AA37DC67D2Q40816184-60F9155F-5524-47D3-84F7-1C7EA68F57B1Q41517260-E71FEB11-DDD1-4A0C-B1E6-14BB5D7645F4Q41810904-407B2D7B-9DD0-4DCF-B248-A24BA95481D0Q42414346-087B258E-C990-470F-95F5-10115D999671Q42436400-0CEBD14F-F04A-4301-B15A-DF26368A10F7Q43252614-428C290A-BA72-47DB-84DF-5D3E19937DB0Q43517004-EE5235F4-DB99-40EA-92DA-A3F4FA8DBC69Q43733891-542D2F14-29B5-4B7C-B82A-EED81E93473CQ43766372-63E28637-5CA8-4C17-9577-CD33C63369B5Q43798561-6F67217A-1D90-472C-BD65-BB7F2B6B2E0DQ44058300-159E7FB6-8C53-4E39-ACF1-8C00B5FD123EQ44060683-E808DA94-EB57-40D1-BE9E-0FB530D4DE1CQ44405191-E91B600F-B356-4640-8A3B-886DA9B757D7Q44796604-7C201E63-6193-494D-B668-6EC85A03C1FAQ46199992-DE9AFDB2-F713-4D50-9BCB-BB318199CFB4Q46348863-E3851093-CFD2-4B0B-B21F-18CEADAE4703Q46629854-50EFE6E7-3022-47A7-9880-7D3A21FD72A2Q47620818-4A230EA1-3909-4523-87A7-52B765AC2625Q47729017-AE8B284E-1B60-4D94-8944-109536376E6BQ51346542-66AA501A-2AE7-46D2-A0DF-B228066DF56CQ51353301-F31227BB-C8C3-4862-82D1-561B00A74B62
P2860
13C-nuclear magnetic resonance spectroscopy studies of hepatic glucose metabolism in normal subjects and subjects with insulin-dependent diabetes mellitus.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
13C-nuclear magnetic resonance ...... n-dependent diabetes mellitus.
@ast
13C-nuclear magnetic resonance ...... n-dependent diabetes mellitus.
@en
type
label
13C-nuclear magnetic resonance ...... n-dependent diabetes mellitus.
@ast
13C-nuclear magnetic resonance ...... n-dependent diabetes mellitus.
@en
prefLabel
13C-nuclear magnetic resonance ...... n-dependent diabetes mellitus.
@ast
13C-nuclear magnetic resonance ...... n-dependent diabetes mellitus.
@en
P2093
P2860
P356
P1476
13C-nuclear magnetic resonance ...... n-dependent diabetes mellitus.
@en
P2093
D L Rothman
G I Shulman
I Magnusson
P2860
P304
P356
10.1172/JCI117602
P407
P577
1994-12-01T00:00:00Z